Makani Science Secures $10M to Pioneer the World’s First Continuous Respiration Monitor

Makani Science is thrilled to announce a successful funding round in which we raised $10,000,000, marking a significant milestone in our mission to revolutionize respiratory health monitoring. As an innovative company, we are at the forefront of developing small, wireless wearable respiratory monitors built with pioneering stretchable electronic sensor technology. This substantial injection of funds will accelerate our journey to create the world's first Continuous Respiration Monitor—a breakthrough device capable of providing seamless, real-time insights into respiratory patterns in everyday settings. Our cutting-edge technology integrates flexible, high-performance sensors into comfortable wearable formats, allowing both healthcare professionals and patients unprecedented access to detailed respiratory analytics. The funds will primarily be used to enhance our product development, scale our manufacturing processes, and conduct extensive clinical trials to validate the monitor's efficacy and reliability. By advancing our design, testing, and regulatory approvals, we aim to not only improve individual patient outcomes but also empower healthcare providers with actionable data for early detection and treatment of respiratory disorders. This investment reaffirms the belief in our vision and technical expertise, and it propels us further in our commitment to improve respiratory care with continuous, non-intrusive monitoring. As we enter this next phase of innovation, we remain dedicated to pushing the boundaries of wearable technology, transforming respiratory health monitoring, and ultimately, enriching lives around the world with smart, accessible health solutions.